- In partnership with the local producer ROSE LifeScience, Following the launch of the Color Cannabis brand in Quebec, the product portfolio has expanded to include Saturday
- The two lines of recreational products now available from the Société québécoise du cannabis (SQDC) where more than 10 Entourage products are offered
TORONTO, Aug.11, 2021 (GLOBE NEWSWIRE) – Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V: ENTG) (OTCQX : WDDMF) (FSE : 4WE) (« Entourage “Or” Society ), A Canadian producer and distributor of cannabis products and brands, is pleased to announce that its brand of recreational cannabis, Saturday Cannabis, is now available in the province of Quebec. After the routing of its first delivery of Saturday’s Lemon Z and Ultra Sour dried flower cultivars to the Société québécoise du cannabis (“SQDC”), Entourage now offers a list of 10 products available in the province through its partnership. with the local producer located in Quebec ROSE LifeScience Inc. (“ROSE”).
The Saturday range thus joins the wide portfolio of recreational products of the Color Cannabis company comprising the cultivars Pedro’s Sweet Sativa, Ghost Train Haze, Mango Haze and Black Sugar Rose in the form of dried flowers and in pre-rolled format.
“We continue to see rapid and impressive growth in the province of Quebec, with record sales and order fulfillment, greatly contributing to the success we have enjoyed during the first half of this year,” said Joseph Mele, vice-president. Senior President, Commerce, Sales and Marketing, Entourage Health. Our products are the top seller in several provincial stores due to our consistent ability to deliver quality cannabis products. In Quebec, we are delighted to work hand in hand with the talented team of marketing and distribution professionals at ROSE LifeScience. “
“In just a few months, we have diversified our product offering in Quebec to include the Saturday Cannabis product line as well as an additional selection of cultivars and Color Cannabis products,” said Davide Zaffino, President and CEO. financial, ROSE LifeScience. Ensure that our province has access to uniform products from producers such as
that Entourage Health is an important step in the continued development of the cannabis industry, both locally and across Canada. “
Visit the new Entourage Health website here. To access our corporate video, click here and to view our most recent investor and corporate presentations, click here.
About ROSE LifeScience Inc.
As a private Quebec company, founded by a group of seasoned executives with extensive experience in heavily regulated industries, ROSE LifeScience is committed to ensuring that Quebec benefits from the responsible production, sale and consumption of cannabis. Whether it is cannabis cultivation, marketing or logistics, ROSE plays a key role in the Quebec market. ROSE not only produces remarkable cannabis, but also offers full marketing services to producers chosen to stimulate a diversified offer in the Quebec market.
About Entourage Health Corp.
Entourage Health Corp. (formerly WeedMD Inc.) is the publicly traded parent company of WeedMD RX Inc., licensee, manufacturer and distributor of cannabis products for the medical and recreational markets. The Company owns and operates a state-of-the-art 158-acre greenhouse, an outdoor processing facility located in Strathroy, Ontario, and a fully licensed 26,000 square foot processing facility, located in Aylmer, Ontario, specializing in cannabis extraction. With the addition of Starseed Medicinal, a brand focused on medicine, Entourage has broadened its multi-channel distribution strategy. Starseed’s exclusive industrial partnership with LiUNA, Canada’s largest construction union, as well as with employers and labor groups, complements Entourage’s direct sales to medical patients. In July 2021, Entourage signed a definitive agreement to acquire artisanal producer CannTx Life Sciences Inc. which operates a pioneering micropropagation and specialized extraction facility in Guelph, Ontario. Beginning with the deal’s expected closing date in August 2021, craft brand Royal City Cannabis will be added to Entourage’s elite product portfolio. The Company maintains strategic relationships with the senior market and supply agreements with Shoppers Drug Mart as well as with eight provincial distribution organizations selling the recreational brands Color Cannabis and Saturday Cannabis. Entourage is also the exclusive Canadian producer and distributor of the award-winning wellness brand Mary’s Medicinals, sold through medical networks and for recreational use in the United States.
For more information, please visit us at: www.entouragehealthcorp.com
Follow Entourage and its brands on LinkedIn
Twitter : Entourage, Color Cannabis, Saturday Cannabis & Starseed
Instagram : Color Cannabis, Saturday Cannabis & Starseed
For more information, please contact:
For investor relations:
Valter Pinto
General director
KCSA Strategic Communications
1-212-896-1254
entourage@kcsa.com
For media relations:
Marianella delaBarrera
Senior Vice-President, Communications and Social Affairs
416-897-6644
marianella@weedmd.com
Caution Regarding Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of applicable provisions of Canadian securities laws which are based on expectations, estimates, prospects, current internal assumptions, beliefs and prospects for events. future of Entourage. Forward-looking statements can usually be recognized by terms such as “expect”, “appear”, “may”, “should”, “intend”, “foresee”, “potential”, “proposed”, ” estimated ”and similar terminology, including the negative form of such terms and variations thereof, or statements to the effect that certain events or conditions“ could ”,“ should ”or“ be expected ”to occur or through discussions relating to The strategy
The forward-looking statements contained in this press release are based on expectations, estimates, projections, assumptions and prospects of future events that management believes to be reasonable under the circumstances. Forward-looking statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidelines or other statements that are not statements of fact. Forward-looking statements necessarily involve known or unknown risks, including, without limitation, risk associated with general economic conditions; events unfavorable to the industry; loss of business; future legislative or regulatory developments; inability to access sufficient capital from internal and external sources and or inability to access sufficient capital on favorable terms; the cannabis industry in Canada generally; Entourage’s ability to implement its business strategies; the COVID-19 pandemic; to competition, to a bad harvest; and other risks.
Forward-looking statements speak only as of the date they are made and, unless required to do so by legislative requirements, Entourage assumes no obligation to update or revise any forward-looking statement, whether in light of new information, future events or otherwise. New factors emerge from time to time and it is impossible for Entourage to predict such factors. In light of these forward-looking statements, readers should be aware of the risk factors and other cautionary statements contained in the disclosure documents disclosed by Entourage, filed with Canadian securities regulatory agencies on SEDAR at address: www.sedar.com. The risk factors and other factors noted in the disclosure documents could lead to actual events or results that could differ materially from those described in any forward-looking statement.
NEITHER THE TSX VENTURE EXCHANGE OR ITS REGULATORY SERVICE PROVIDER (AS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ASSUMES RESPONSIBILITY FOR THE ACCURACY OR ACCURACY OF THIS PRESS RELEASE.
